KIRKLAND, Wash., June 25 /PRNewswire/ -- Pathway Medical Technologies, Inc., an innovator of endovascular treatments for peripheral arterial disease (PAD), announced it was recently granted another patent for its Pathway PV(TM) Atherectomy System. The issuance of this latest patent enhances the intellectual property related to Pathway Medical's innovative atherectomy system, which is designed to treat the difficult arterial disease found in the legs. Pathway Medical has a total of three patents issued by the U.S. patent office relating to differential cutting and the removal of atherosclerotic plaque for its rotational atherectomy system.
"This latest patent is one more addition to a robust intellectual property portfolio covering key aspects of our system," said Ted Wulfman, CTO and co-founder of Pathway Medical. "We continue to pursue a strategy of building a strong intellectual property portfolio to protect the many inventions and systems related to this innovative atherectomy technology." Mr. Wulfman noted there are several other patents pending.
About Pathway Medical Technologies, Inc.
Pathway Medical Technologies, Inc. was founded to design, market and manufacture medical devices for the treatment of arterial disease. The company's initial focus is treating peripheral arterial disease (PAD) more quickly and effectively than existing technologies. An estimated 8-12 million people are afflicted by PAD in the U.S., and that number is projected to grow to over 20 million during the next 10 years. The company's Pathway PV(TM) Atherectomy System allows for a minimally invasive procedure designed to restore circulation in the peripheral arteries by removing both hard and soft diseased tissue. For further information, visit the company's Web site at www.pathwaymedical.com.
CONTACT: Thomas J. Clement, CEO and President, +1-425-636-4122,
clementt@pathwaymedical.com
Web site: http://www.pathwaymedical.com/
